MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer
Authors
Keywords
Breast carcinoma, Tumor-infiltrating lymphocytes, Human leukocyte antigen, Interferon, Myxovirus resistance A
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 156, Issue 3, Pages 597-606
Publisher
Springer Nature
Online
2016-04-14
DOI
10.1007/s10549-016-3786-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab
- (2015) Hee Jin Lee et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- FOXA2 mRNA expression is associated with relapse in patients with Triple-Negative/Basal-like breast carcinoma
- (2015) Ariadna Perez-Balaguer et al. BREAST CANCER RESEARCH AND TREATMENT
- Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancer
- (2015) Hua Zhang et al. BREAST CANCER RESEARCH AND TREATMENT
- Novel role of PELP1 in regulating chemotherapy response in mutant p53-expressing triple negative breast cancer cells
- (2015) Samaya R. Krishnan et al. BREAST CANCER RESEARCH AND TREATMENT
- Therapies for triple negative breast cancer
- (2015) Eleni Andreopoulou et al. EXPERT OPINION ON PHARMACOTHERAPY
- Immunotherapeutic options on the horizon in breast cancer treatment
- (2015) Johan M. van Rooijen et al. PHARMACOLOGY & THERAPEUTICS
- Mx GTPases: dynamin-like antiviral machines of innate immunity
- (2015) Otto Haller et al. TRENDS IN MICROBIOLOGY
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- Low Prognostic Implication of Fibroblast Growth Factor Family Activation in Triple-negative Breast Cancer Subsets
- (2014) Hee Jin Lee et al. ANNALS OF SURGICAL ONCOLOGY
- Quantitative proteome profiling of lymph node-positivevs. -negative colorectal carcinomas pinpoints MX1 as a marker for lymph node metastasis
- (2014) Roland S. Croner et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
- (2014) Sylvia Adams et al. JOURNAL OF CLINICAL ONCOLOGY
- Subtype-dependent prognostic relevance of an interferon-induced pathway metagene in node-negative breast cancer
- (2014) Maurizio Callari et al. Molecular Oncology
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
- (2014) Antonella Sistigu et al. NATURE MEDICINE
- Interferon inducible antiviral MxA is inversely associated with prostate cancer and regulates cell cycle, invasion and Docetaxel induced apoptosis
- (2014) Shanora G. Brown et al. PROSTATE
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Tumor-Associated Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
- (2013) Hee Jin Lee et al. Journal of Breast Cancer
- Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
- (2013) Sherene Loi et al. JOURNAL OF CLINICAL ONCOLOGY
- Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapy
- (2013) Yu-Ping Liu et al. Scientific Reports
- Androgen receptor in triple negative breast cancer
- (2012) K.M. McNamara et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Establishment of a monoclonal anti-pan HLA class I antibody suitable for immunostaining of formalin-fixed tissue: Unusually high frequency of down-regulation in breast cancer tissues
- (2012) Toshihiko Torigoe et al. PATHOLOGY INTERNATIONAL
- Expression Signature of IFN/STAT1 Signaling Genes Predicts Poor Survival Outcome in Glioblastoma Multiforme in a Subtype-Specific Manner
- (2012) Christine W. Duarte et al. PLoS One
- Type 1 Interferons and Antiviral CD8 T-Cell Responses
- (2012) Raymond M. Welsh et al. PLoS Pathogens
- Induction of Interferon Pathways Mediates In Vivo Resistance to Oncolytic Adenovirus
- (2011) Ilkka Liikanen et al. MOLECULAR THERAPY
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. Journal of Oncology Practice
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2009) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic Alterations and Oncogenic Pathways Associated with Breast Cancer Subtypes
- (2009) X. Hu et al. MOLECULAR CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started